Seminars in Perinatology
Volume 31, Issue 4 , Pages 254-261 , August 2007

Erythrocyte Disorders in the Perinatal Period

  • Laurie A. Steiner
    • ,
  • Patrick G. Gallagher

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Patrick G. Gallagher, Department of Pediatrics, Yale University School of Medicine, 333 Cedar Street, P.O. Box 208064, New Haven, CT 06520-8064.

References 

  1. In:  Handin RI,  Lux SE,  Stossel TP editor. Blood (Principles and Practices of Hematology). Philadelphia, PA: Lippincott; 2003;
  2. Forestier F, Daffos F, Catherine N, et al. Developmental hematopoiesis in normal human fetal blood. Blood. 1991;77:2360–2363
  3. Zipurksy A, Brown E, Palko J, et al. The erythrocyte differential in newborn infants. Am J Pediatr Hematol Oncol. 1983;5:45–51
  4. In:  Christensen RD editors. Hematologic Problems of the Neonate. Philadelphia, PA: WB Saunders; 2000;
  5. Holroyde CP, Oski FA, Gardner FH. The “pocked” erythrocyte (Red-cell surface alterations in reticuloendothelial immaturity of the neonate). N Engl J Med. 1969;281:516–520
  6. Pearson HA. Life-span of the fetal red blood cell. J Pediatr. 1967;70:166–171
  7. Kleihauer E, Braun H, Betke K. Demonstration of fetal hemoglobin in erythrocytes of a blood smear. Klin Wochenschr. 1957;35:637–638
  8. Gross RT, Bracci R, Rudolph N, et al. Hydrogen peroxide toxicity and detoxification in the erythrocytes of newborn infants. Blood. 1967;29:481–493
  9. Luzzatto L. Genetics of red cells and susceptibility to malaria. Blood. 1979;54:961–976
  10. Higgs DR, Vickers MA, Wilkie AO, et al. A review of the molecular genetics of the human alpha-globin gene cluster. Blood. 1989;73:1081–1104
  11. Chan V, Chan TK, Liang ST, et al. Hydrops fetalis due to an unusual form of Hb H disease. Blood. 1985;66:224–228
  12. Ko TM, Hseih FJ, Hsu PM, et al. Molecular characterization of severe alpha-thalassemias causing hydrops fetalis in Taiwan. Am J Med Genet. 1991;39:317–320
  13. Chan V, Chan VW, Tang M, et al. Molecular defects in Hb H hydrops fetalis. Br J Haematol. 1997;96:224–228
  14. Ne-Win , Harano K, Harano T, et al. Common alpha-thalassemia deletions in transfusion-dependent thalassemia patients in the Southeast Asia region of Myanmar. Lab Hematol. 2006;12:139–142
  15. Chui DH, Waye JS. Hydrops fetalis caused by alpha-thalassemia: an emerging healthcare problem. Blood. 1998;91:2213–2222
  16. Hofstaetter C, Gonser M, Goelz R. Perinatal case report of unexpected thalassemia Hb Bart. Fetal Diagn Ther. 1993;8:418–422
  17. Guy G, Coady DJ, Jansen V, et al. alpha-Thalassemia hydrops fetalis: clinical and ultrasonographic considerations. Am J Obstet Gynecol. 1985;153:500–504
  18. Liang ST, Wong VC, So WW, et al. Homozygous alpha-thalassaemia: clinical presentation, diagnosis and management (A review of 46 cases). Br J Obstet Gynaecol. 1985;92:680–684
  19. Singer ST, Styles L, Bojanowski J, et al. Changing outcome of homozygous alpha-thalassemia: cautious optimism. J Pediatr Hematol Oncol. 2000;22:539–542
  20. Pirastu M, Kan YW, Lin CC, et al. Hemolytic disease of the newborn caused by a new deletion of the entire beta-globin cluster. J Clin Invest. 1983;72:602–609
  21. Orkin SH, Goff SC, Nathan DG. Heterogeneity of DNA deletion in gamma delta beta-Thalassemia. J Clin Invest. 1981;67:878–884
  22. Fortina P, Delgrosso K, Werner E, et al. A greater than 200 kb deletion removing the entire beta-like globin gene cluster in a family of Irish descent. Hemoglobin. 1991;15:23–41
  23. Driscoll MC, Dobkin CS, Alter BP. Gamma delta beta-Thalassemia due to a de novo mutation deleting the 5′ beta-globin gene activation–region hypersensitive sites. Proc Natl Acad Sci U S A. 1989;86:7470–7474
  24. Curtin PT, Kan YW. The inactive beta globin gene on a gamma delta beta thalassemia chromosome has a normal structure and functions normally in vitro. Blood. 1988;71:766–770
  25. Kan YW, Forget BG, Nathan DG. Gamma-beta Thalassemia: a cause of hemolytic disease of the newborn. New Engl J Med. 1972;286:129–134
  26. Bollekens JA, Forget BG. Delta beta thalassemia and hereditary persistence of fetal hemoglobin. Hematol Oncol Clin North Am. 1991;5:399–422
  27. In:  Steinberg MH,  Forget BG,  Higgs DR, et al. editor. Disorders of Hemoglobin (Genetics, Pathophysiology, and Clinical Management). Cambridge: Cambridge University Press; 2001;
  28. Lee-Potter JP, Deacon-Smith RA, Simpkiss MJ, et al. A new cause of haemolytic anaemia in the newborn (A description of an unstable fetal haemoglobin: F Poole, alpha2-G-gamma2 130 trptophan yields glycine). J Clin Pathol. 1975;28:317–320
  29. Charache S, Mondzac AM, Gessner U. Hemoglobin Hasharon (α247 his(CD5)β2): a hemoglobin found in low concentration. J Clin Invest. 1969;48:834–847
  30. Pissard S, Max-Audit I, Skopinski L, et al. Pyruvate kinase deficiency in France: a 3-year study reveals 27 new mutations. Br J Haematol. 2006;133:683–689
  31. Gilsanz F, Vega MA, Gomez-Castillo E, et al. Fetal anemia due to pyruvate kinase deficiency. Arch Dis Child. 1993;69:523–524
  32. Hennekam RC, Beemer FA, Cats BP, et al. Hydrops fetalis associated with red cell pyruvate kinase deficiency. Genet Couns. 1990;1:75–79
  33. Demina A, Varughese KI, Barbot J, et al. Six previously undescribed pyruvate kinase mutations causing enzyme deficiency. Blood. 1998;92:647–652
  34. Zanella A, Bianchi P. Red cell pyruvate kinase deficiency: from genetics to clinical manifestations. Baillieres Best Pract Res Clin Haematol. 2000;13:57–81
  35. Diaz A, Gilsanz F, Martinez J, et al. Life-threatening nonspherocytic hemolytic anemia in a patient with a null mutation in the PKLR gene and no compensatory PKM gene expression. Blood. 2005;106:1851–1856
  36. Costa C, Albuisson J, Le TH, et al. Severe hemolytic anemia in a Vietnamese family associated with novel mutations in the gene encoding for pyruvate kinase. Haematologica. 2005;90:25–30
  37. Bianchi P, Zanella A. Hematologically important mutations: red cell pyruvate kinase. (Third Update) Blood Cells Mol Dis. 2000;26:47–53
  38. Lenzner C, Nurnberg P, Jacobasch G, et al. Molecular analysis of 29 pyruvate kinase-deficient patients from central Europe with hereditary hemolytic anemia. Blood. 1997;89:1793–1799
  39. Kanno H, Fujii H, Wei DC, et al. Frame shift mutation, exon skipping, and a two codon deletion caused by splice site mutations account for pyruvate kinase deficiency. Blood. 1997;89:4213–4218
  40. van Wijk R, van Solinge WW, Nerlov C, et al. Disruption of a novel regulatory element in the erythroid-specific promoter of the human PKLR gene causes severe pyruvate kinase deficiency. Blood. 2003;101:1596–1602
  41. Suvatte V, Tanphaichitr VS, Visuthisakchai S, et al. Bone marrow, peripheral blood and cord blood stem cell transplantation in children: ten years’ experience at Siriraj Hospital. Int J Hematol. 1998;68:411–419
  42. Mehta A, Mason PJ, Vulliamy TJ. Glucose-6-Phosphate dehydrogenase deficiency. Baillieres Best Pract Res Clin Haematol. 2000;13:21–38
  43. Ruwende C, Khoo SC, Snow RW, et al. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature. 1995;376:246–249
  44. Ursini MV, Parrella A, Rosa G, et al. Enhanced expression of glucose-6-phosphate dehydrogenase in human cells sustaining oxidative stress. Biochem J. 1997;323:801–806
  45. Salvemini F, Franze A, Iervolino A, et al. Enhanced glutathione levels and oxidoresistance mediated by increased glucose-6-phosphate dehydrogenase expression. J Biol Chem. 1999;274:2750–2757
  46. Gaetani GD, Parker JC, Kirkman HN. Intracellular restraint: a new basis for the limitation in response to oxidative stress in human erythrocytes containing low-activity variants of glucose-6-phosphate dehydrogenase. Proc Natl Acad Sci U S A. 1974;71:3584–3587
  47. Perkins RP. Hydrops fetalis and stillbirth in a male glucose-6-phosphate dehydrogenase-deficient fetus possibly due to maternal ingestion of sulfisoxazole; a case report. Am J Obstet Gynecol. 1971;111:379–381
  48. Mentzer WC, Collier E. Hydrops fetalis associated with erythrocyte G-6-PD deficiency and maternal ingestion of fava beans and ascorbic acid. J Pediatr. 1975;86:565–567
  49. Corchia C, Balata A, Meloni GF, et al. Favism in a female newborn infant whose mother ingested fava beans before delivery. J Pediatr. 1995;127:807–808
  50. Kaplan M, Vreman HJ, Hammerman C, et al. Favism by proxy in nursing glucose-6-phosphate dehydrogenase-deficient neonates. J Perinatol. 1998;18:477–479
  51. Kaplan M, Leiter C, Hammerman C, et al. Comparison of commercial screening tests for glucose-6-phosphate dehydrogenase deficiency in the neonatal period. Clin Chem. 1997;43:1236–1237
  52. American Academy of Pediatrics. Management of hyperbilirubinemia in the newborn infant 35 weeks or more of gestation. Pediatrics. 2004;114:297–316
  53. Eber SW, Pekrun A, Neufeldt A, et al. Prevalence of increased osmotic fragility of erythrocytes in German blood donors: screening using a modified glycerol lysis test. Ann Hematol. 1992;64:88–92
  54. Godal HC, Heisto H. High prevalence of increased osmotic fragility of red blood cells among Norwegian blood donors. Scand J Hematol. 1981;27:30–34
  55. Lux S, Tse W, Menninger J, et al. Hereditary spherocytosis associated with deletion of human erythrocyte ankyrin gene on chromosome 8. Nature. 1990;345:736–739
  56. Gallagher PG. Update on the clinical spectrum and genetics of red blood cell membrane disorders. Curr Hematol Rep. 2004;3:85–91
  57. Gallagher PG. Red cell membrane disorders. Hematol Am Soc Hematol Educ Prog. 2005;13–18
  58. Whitfield CF, Follweiler JB, Lopresti-Morrow L, et al. Deficiency of α-spectrin synthesis in burst-forming units-erythroid in lethal hereditary spherocytosis. Blood. 1991;78:3043–3051
  59. Gallagher PG, Weed SA, Tse WT, et al. Recurrent fatal hydrops fetalis associated with a nucleotide substitution in the erythrocyte beta-spectrin gene. J Clin Invest. 1995;95:1174–1182
  60. Gallagher PG, Petruzzi MJ, Weed SA, et al. Mutation of a highly conserved residue of beta spectrin associated with fatal and near-fatal neonatal hemolytic anemia. J Clin Invest. 1997;99:267–277
  61. Zarkowsky HS, Mohandas N, Speaker CB, et al. A congenital haemolytic anaemia with thermal sensitivity of the erythrocyte membrane. Br J Haematol. 1975;4:537–543
  62. MacDougall LG, Moodley G, Quirk M. The pyropoikilocytosis-elliptocytosis syndrome in a black South African infant: clinical and hematological features. Am J Pediatr Hematol Oncol. 1982;3:344–349
  63. Zhang Z, Weed SA, Gallagher PG, et al. Dynamic molecular modeling of pathogenic mutations in the spectrin self-association domain. Blood. 2001;98:1645–1653
  64. Delaunay J, Stewart G, Iolascon A. Hereditary dehydrated and overhydrated stomatocytosis: recent advances. Curr Opin Hematol. 1999;6:110–114
  65. Grootenboer-Mignot S, Cretien A, Laurendeau I, et al. Sub-lethal hydrops as a manifestation of dehydrated hereditary stomatocytosis in two consecutive pregnancies. Prenat Diagn. 2003;23:380–384
  66. Vicente-Gutierrez MP, Castello-Almazan I, Salvia-Roiges MD, et al. Nonimmune hydrops fetalis due to congenital xerocytosis. J Perinatol. 2005;25:63–65
  67. Entezami M, Becker R, Menssen HD, et al. Xerocytosis with concomitant intrauterine ascites: first description and therapeutic approach. Blood. 1996;87:5392–5393
  68. Sanchez M, Palacio M, Borrell A, et al. Prenatal diagnosis and management of fetal xerocytosis associated with ascites. Fetal Diagn Ther. 2005;20:402–405
  69. Grootenboer S, Schischmanoff PO, Laurendeau I, et al. Pleiotropic syndrome of dehydrated hereditary stomatocytosis, pseudohyperkalemia, and perinatal edema maps to 16q23-q24. Blood. 2000;96:2599–2605
  70. Stewart GW, Amess JA, Eber SW, et al. Thrombo-embolic disease after splenectomy for hereditary stomatocytosis. Br J Haematol. 1996;93:303–310
  71. Da Costa L, Willig TN, Fixler J, et al. Diamond-Blackfan anemia. Curr Opin Pediatr. 2001;13:10–15
  72. Rogers BB, Bloom SL, Buchanan GR. Autosomal dominantly inherited Diamond-Blackfan anemia resulting in nonimmune hydrops. Obstet Gynecol. 1997;89:805–807
  73. Saladi SM, Chattopadhyay T, Adiotomre PN. Nonimmune hydrops fetalis due to Diamond Blackfan anemia. Ind Pediatr. 2004;41:187–188
  74. Roy V, Perez WS, Eapen M, et al. Non-malignant marrow disorders working committee of the International Bone Marrow Transplant Registry (Bone marrow transplantation for Diamond-Blackfan anemia). Biol Blood Marrow Transplant. 2005;11:600–608
  75. Makitie O, Ellis L, Durie PR, et al. Skeletal phenotype in patients with Shwachman-Diamond syndrome and mutations in SBDS. Clin Genet. 2004;65:101–112
  76. Shwachman H, Diamond LK, Oski FA, et al. The syndrome of pancreatic insufficiency and bone marrow dysfunction. J Pediatr. 1964;65:645–663
  77. Dror Y, Freedman MH. Shwachman-diamond syndrome. Br J Haematol. 2002;118:701–713
  78. Kato K, Sugitani M, Kawataki M, et al. Congenital dyserythropoietic anemia type 1 with fetal onset of severe anemia. J Pediatr Hematol Oncol. 2001;23:63–66
  79. Shalev H, Kapelushnik J, Moser A, et al. A comprehensive study of the neonatal manifestations of congenital dyserythropoietic anemia type I. J Pediatr Hematol Oncol. 2004;26:746–748
  80. Remacha AF, Badell I, Pujol-Moix N, et al. Hydrops fetalis-associated dyserythropoietic anemia treated with intrauterine transfusions and bone marrow transplantation. Blood. 2002;100:356–358
  81. Li CH, Lam CW, Lee CW, et al. Pearson’s syndrome: a rare cause of non-immune hydrops fetalis. Chin Med J (Engl). 2003;116:1952–1954
  82. Jacobs LJ, Jongbloed RJ, Wijburg FA, et al. Pearson syndrome and the role of deletion dimmers and duplications in the mtDNA. J Inherit Metab Dis. 2004;27:47–55
  83. Knerr I, Metzler M, Niemeyer CM, et al. Hematologic features and clinical course of an infant with Pearson syndrome caused by a novel deletion of mitochondrial DNA. J Pediatr Hematol Oncol. 2003;25:948–951
  84. Muis N, Beemer FA, van Dijken P, et al. The Aase syndrome (Case report and review of the literature). Eur J Pediatr. 1986;145:153–157
  85. Auerbach AD, Wolman SR. Susceptibility of Fanconi’s anaemia fibroblasts to chromosome damage by carcinogens. Nature. 1976;261:494–496
  86. Auerbach AD. Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp Hematol. 1993;21:731–733
  87. German J, Schonberg S, Caskie S, et al. A test for Fanconi’s anemia. Blood. 1987;69:1637–1641
  88. Taniguchi T, Garcia-Higuera I, Xu B, et al. Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways. Cell. 2002;109:459–472
  89. MacMillan ML, Auerbach AD, Davies SM, et al. Haematopoietic cell transplantation in patients with Fanconi anaemia using alternate donors: results of a total body irradiation dose escalation trial. Br J Haematol. 2000;109:121–129
  90. Grewal SS, Kahn JP, MacMillan ML, et al. Successful hematopoietic stem cell transplantation for Fanconi anemia from an unaffected HLA-genotype-identical sibling selected using preimplantation genetic diagnosis. Blood. 2004;103:1147–1151

PII: S0146-0005(07)00062-6

doi: 10.1053/j.semperi.2007.05.003

Seminars in Perinatology
Volume 31, Issue 4 , Pages 254-261 , August 2007

Article Tools

* Image Usage & Resolution